Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|November 7, 2024
A comprehensive study on the rheological properties of desulfurized rubberized asphalt and establishment of micro-scale mechanical modelsYingjie Chang
Chemical Communications (Cambridge, England)|March 18, 2025
General aggregation-induced deposition approach for creating asymmetric single-atom catalystsYutong Liao, Yingjie Chang, Yanqing Wang, et al.
The Journal of Physical Chemistry Letters|March 7, 2025
Electron-Coupling Effect Modulating the d-Band Center of Asymmetric Cobalt Single-Atom Sites for Electrocatalytic Oxygen ReductionQi Li, Yingjie Chang, Yutong Liao, et al.
Inorganic Chemistry|June 8, 2026
Compressing Platinum Lattices for Durable Oxygen Electrocatalysis in Zinc-Air Battery CathodesYingjie Chang, Yu Wang, Yanqing Wang, et al.
Chemical Communications (Cambridge, England)|May 21, 2025
Engineering a molecular-sieving architecture on poly(ionic liquid)-functionalized UiO-66-NH2 membranes toward CO2/N2 separationLiangmei Luo, Yingjie Chang, Yutong Liao, et al.
The Science of the Total Environment|December 29, 2023
Occurrence characteristics and risk assessment of microplastics in agricultural soils in the loess hilly gully area of Yan' an, ChinaZhifeng Jia, Wei Wei, Yanhua Wang, et al.
European Journal of Medicinal Chemistry|September 12, 2024
Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemiaYingjie Chang, Xue Li, Yue Zhou, et al.
ACS Applied Materials & Interfaces|October 17, 2025
Twisted Conductive Fiber-Based Strain Sensor with High Sensitivity and Wide Working Range for Human Motion Recognition and Physiological Activity MonitoringLeyu Dai, Zhichao Zhou, Yingjie Chang, et al.
Bioorganic & Medicinal Chemistry|March 5, 2026
Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitorsWen Li, Ruixue Cheng, Yingjie Chang, et al.
Journal of Medicinal Chemistry|September 12, 2024
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor ImmunityYingjie Chang, Huahui Guo, Xue Li, et al.
Pageof 2